LASCO Pharmaceutical, Bayer launch drug to treat chronic kidney disease
Bayer Healthcare, in partnership with LASCO Pharmaceutical Division, has introduced finerenone, a groundbreaking drug, branded as Firialta, for the treatment of chronic kidney disease (CKD). It is estimated that 300,000 Jamaicans, approximately 10...
Hortense Edwards Juan Carlos Ramirez Sandoval Ramirez Sandoval Ramirez Sandolval Department Of Nephrology National Institute Of Medical Science
Source: jamaica-gleaner.com